ClusterOS Diagnostic Profile
Belfast LifeSciences
Belfast LifeSciences runs on 81 evidence items (Belfast LifeSciences UKRI grants: 129 grants, £164m total, 26 distinct lead o). The diagnostic resolves a Extraction-Narrative configuration at MEDIUM confidence.
Value extraction events generate narrative about ecosystem success; narrative legitimises continued extraction by framing it as ecosystem contribution; uncertainty about whether extraction is harmful absorbed by the success narrative.
Intermediaries produce narrative about their facilitation role; narrative legitimises intermediary existence and funding; uncertainty about direct coupling absorbed by narrative rather than demonstration.
"If one public reporting body (e.g., Invest NI from P014, or Belfast City Region Deal governance from P006) separated "value created" metrics (equity raised, grants won) from "value retained" metrics (local employment post-exit, IP licensed back to cluster, follow-on capital from local sources), it might expose whether success narratives reflect ecosystem retention or external...
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.